Development of In Vivo Models to Study Oncolytic Viral Therapies in Combination Treatments
Time: 8:35 am
day: Conference Day Two
Details:
• Overcoming the complexity of tumour biology and complex therapeutic interactions
• Spotlighting techniques to engineer mouse cell lines to better study oncolytic viruses
• Understanding strategies to combine oncolytic viruses with CAR-T cells for therapy
